about
Clinical features and outcomes of 139 Japanese patients with Hodgkin lymphoma.A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma.High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma.Donor lymphocyte infusion is an effective therapy for relapsed Hodgkin lymphoma after reduced-intensity allogeneic hematopoietic stem cell transplantation.Classical Hodgkin lymphoma primary refractory to brentuximab vedotin, with transformation to CD30-positive diffuse large B-cell lymphoma.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Advances in the treatment of Hodgkin lymphoma.
@en
type
label
Advances in the treatment of Hodgkin lymphoma.
@en
prefLabel
Advances in the treatment of Hodgkin lymphoma.
@en
P2860
P1476
Advances in the treatment of Hodgkin lymphoma.
@en
P2093
Andreas Engert
Dennis A Eichenauer
P2860
P2888
P304
P356
10.1007/S12185-012-1199-2
P577
2012-10-11T00:00:00Z
P5875
P6179
1044228547